Optimizing PTCy Dose and Timing

Clinical trial NCT03983850 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03983850
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Graft Versus Host Disease Hematologic Neoplasms

Start date: 2019-07-09
Primary completion: 2025-11-25
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.